These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34149812)

  • 1. Multi-Omics Marker Analysis Enables Early Prediction of Breast Tumor Progression.
    Xu H; Lien T; Bergholtz H; Fleischer T; Djerroudi L; Vincent-Salomon A; Sørlie T; Aittokallio T
    Front Genet; 2021; 12():670749. PubMed ID: 34149812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions.
    Bergholtz H; Lien TG; Swanson DM; Frigessi A; ; Daidone MG; Tost J; Wärnberg F; Sørlie T
    NPJ Breast Cancer; 2020; 6():26. PubMed ID: 32577501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer.
    Mangé A; Lacombe J; Bascoul-Mollevi C; Jarlier M; Lamy PJ; Rouanet P; Maudelonde T; Solassol J
    Clin Cancer Res; 2012 Apr; 18(7):1992-2000. PubMed ID: 22322670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
    Schultz S; Bartsch H; Sotlar K; Petat-Dutter K; Bonin M; Kahlert S; Harbeck N; Vogel U; Seeger H; Fehm T; Neubauer HJ
    BMC Med Genomics; 2018 Sep; 11(1):80. PubMed ID: 30236106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of an oligo-gene signature for the prognostic stratification of ductal carcinoma in situ (DCIS).
    Geradts J; Groth J; Wu Y; Jin G
    Breast Cancer Res Treat; 2016 Jun; 157(3):447-59. PubMed ID: 27250000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and transfer of spatial transcriptomics signatures for cancer diagnosis.
    Yoosuf N; Navarro JF; Salmén F; Ståhl PL; Daub CO
    Breast Cancer Res; 2020 Jan; 22(1):6. PubMed ID: 31931856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Molecular Portrait of High-Grade Ductal Carcinoma In Situ.
    Abba MC; Gong T; Lu Y; Lee J; Zhong Y; Lacunza E; Butti M; Takata Y; Gaddis S; Shen J; Estecio MR; Sahin AA; Aldaz CM
    Cancer Res; 2015 Sep; 75(18):3980-90. PubMed ID: 26249178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.
    Johnson KC; Koestler DC; Fleischer T; Chen P; Jenson EG; Marotti JD; Onega T; Kristensen VN; Christensen BC
    Clin Epigenetics; 2015; 7(1):75. PubMed ID: 26213588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Machine Learning of Breast Pathology Structures for Automated Differentiation of Breast Cancer and High-Risk Proliferative Lesions.
    Mercan E; Mehta S; Bartlett J; Shapiro LG; Weaver DL; Elmore JG
    JAMA Netw Open; 2019 Aug; 2(8):e198777. PubMed ID: 31397859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CA mutations in ductal carcinoma in situ and adjacent invasive breast cancer.
    Agahozo MC; Sieuwerts AM; Doebar SC; Verhoef EI; Beaufort CM; Ruigrok-Ritstier K; de Weerd V; Sleddens HFBM; Dinjens WNM; Martens JWM; van Deurzen CHM
    Endocr Relat Cancer; 2019 May; 26(5):471-482. PubMed ID: 30844755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
    Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK
    Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation in ductal carcinoma in situ of the male breast.
    Vermeulen MA; van Deurzen CHM; Doebar SC; de Leng WWJ; Martens JWM; van Diest PJ; Moelans CB
    Endocr Relat Cancer; 2019 Jun; 26(6):575-584. PubMed ID: 30921768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of ductal carcinoma in situ to invasive breast cancer: comparative genomic sequencing.
    Doebar SC; Krol NM; van Marion R; Brouwer RWW; van Ijcken WFJ; Martens JM; Dinjens WNM; van Deurzen CHM
    Virchows Arch; 2019 Feb; 474(2):247-251. PubMed ID: 30284611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study.
    Soon PS; Provan PJ; Kim E; Pathmanathan N; Graham D; Clarke CL; Balleine RL
    Clin Exp Metastasis; 2018 Feb; 35(1-2):3-13. PubMed ID: 29214365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mammography screening detection of ductal carcinoma in situ and invasive breast cancer according to women's characteristics: is it the same?
    Théberge I; Vandal N; Guertin MH; Perron L
    Breast Cancer Res Treat; 2019 Apr; 174(2):525-535. PubMed ID: 30564969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2, p16 and Ki67 expression in DCIS, microinvasive and early invasive breast carcinoma with extensive intraductal component.
    Bartova M; Ondrias F; Muy-Kheng T; Kastner M; Singer Ch; Pohlodek K
    Bratisl Lek Listy; 2014; 115(7):445-51. PubMed ID: 25077370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Differences between Ductal Carcinoma in Situ with and without Progression to Invasive Breast Cancer.
    Doebar SC; Sieuwerts AM; de Weerd V; Stoop H; Martens JWM; van Deurzen CHM
    Am J Pathol; 2017 Jul; 187(7):1648-1655. PubMed ID: 28634007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductal Carcinoma In Situ Progression in Dog Model of Breast Cancer.
    Mohammed SI; Utturkar S; Lee M; Yang HH; Cui Z; Atallah Lanman N; Zhang G; Ramos Cardona XE; Mittal SK; Miller MA
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32053966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation landscape of triple-negative ductal carcinoma in situ (DCIS) progressing to the invasive stage in canine breast cancer.
    Beetch M; Harandi-Zadeh S; Yang T; Boycott C; Chen Y; Stefanska B; Mohammed SI
    Sci Rep; 2020 Feb; 10(1):2415. PubMed ID: 32051475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.